13D/13G Filings - U.S. Venture Partners XI L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-01
1:38 pm
Sale
2022-02-25 13D Edgewise Therapeutics, Inc.
EWTX
U.S. Venture Partners XI L.P. 15,625
0.000%
-3,473,543decrease
(-99.55%)
Filing
History
2021-04-30
6:44 pm
Purchase
2021-03-30 13D Edgewise Therapeutics, Inc.
EWTX
U.S. Venture Partners XI L.P. 3,489,168
7.100%
3,489,168increase
(New Position)
Filing
History